HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Persisting Muscle Dysfunction in Cushing's Syndrome Despite Biochemical Remission.

AbstractCONTEXT:
Glucocorticoid-induced myopathy is a characteristic symptom of endogenous Cushing's syndrome (CS). Its long-term outcome is largely unknown.
OBJECTIVE:
To evaluate long-term muscle function following the remission of endogenous CS.
STUDY DESIGN:
Observational longitudinal cohort study.
SETTING:
Tertiary care hospitals and a specialized outpatient clinic.
PATIENTS:
As part of the prospective multicenter German Cushing's Registry, we assessed muscle strength in patients with overt endogenous CS. We studied the patients at the time of diagnosis (n = 88), after 6 months (n = 69), and thereafter annually, following surgical remission over a period of up to 4 years (1 year: n = 55; 2 years: n = 34; 3 years: n = 29; 4 years: n = 22). Muscle function was evaluated by hand grip strength and by chair rising test.
RESULTS:
Grip strength was decreased to 83% of normal controls (100%) at the time of diagnosis. It further decreased to 71% after 6 months in remission (P ≤ 0.001) and showed no improvement during further follow-up compared with baseline. Chair rising test performance improved initially (8 seconds at baseline vs 7 seconds after 6 months, P = 0.004) but remained at this reduced level thereafter (7 seconds after 3 years vs 5 seconds in controls, P = 0.038). In multivariate analysis, we identified, as predictors for long-term muscle dysfunction, age, waist-to-hip ratio, and hemoglobin A1c at baseline. Furthermore, muscle strength during follow-up was strongly correlated with quality of life.
CONCLUSION:
This study shows that CS-associated myopathy does not spontaneously resolve during remission. This calls for action to identify effective interventions to improve muscle dysfunction in this setting.
AuthorsFrederick Vogel, Leah T Braun, German Rubinstein, Stephanie Zopp, Heike Künzel, Finn Strasding, Adriana Albani, Anna Riester, Ralf Schmidmaier, Martin Bidlingmaier, Marcus Quinkler, Timo Deutschbein, Felix Beuschlein, Martin Reincke
JournalThe Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab) Vol. 105 Issue 12 (12 01 2020) ISSN: 1945-7197 [Electronic] United States
PMID32882010 (Publication Type: Journal Article, Multicenter Study, Observational Study, Research Support, Non-U.S. Gov't)
Copyright© Endocrine Society 2020.
Chemical References
  • Biomarkers
Topics
  • Adult
  • Biomarkers (analysis)
  • Case-Control Studies
  • Cohort Studies
  • Cushing Syndrome (complications, diagnosis, physiopathology, surgery)
  • Female
  • Germany
  • Hand Strength (physiology)
  • Humans
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Muscle Strength (physiology)
  • Muscular Diseases (diagnosis, etiology, physiopathology, surgery)
  • Prognosis
  • Quality of Life
  • Remission Induction
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: